Open AccessPersistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
Author(s) -
Otsuka Yasuyuki,
Nishikori Momoko,
Kitano Toshiyuki,
Oka Tomomi,
Ishikawa Takayuki,
Haga Hironori,
TakaoriKondo Akifumi
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.872
Subject(s) - mantle cell lymphoma , medicine , splenectomy , lymphoma , clone (java method) , spleen , biology , genetics , dna
Key Clinical Message We report here a patient with extremely indolent mantle cell lymphoma ( MCL ) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.